After the publication of our December 2007 supplement, “Health-related Quality of Life in Rheumatoid Arthritis,” the Editors learned that several authors were not given the opportunity to review the final proofs of their manuscripts. As a result, the following errors were subsequently identified. First, the co-author’s name was inadvertently omitted from the Introduction. The correct byline for the Introduction should read: Daniel E. Furst, MD, and Dinesh Khanna, MD.
Second, in the article “Generic Quality-of-life Assessment in Rheumatoid Arthritis,” by Tugwell, et al (Am J Manag Care. 2007;13[suppl 9]:S224-S236), some of the indicators for Health Dimension and Psychometric Properties were missing from Table 1; some data in Table 3 were incorrect; and the reference numbers in Figures 1a and 1b were misnumbered. The corrected tables and figures appear on the following pages (see pages 235-238).
Finally, due to the extent of the errors in the article by Strand et al, “Improved Health-related Quality of Life With Effective Disease-modifying Antirheumatic Drugs: Evidence From Randomized Controlled Trials,” we are reprinting a corrected version of this article in this issue (see pages 239-253).

HEDIS Glycemic Goal Achieved Using Control-IQ Technology
December 22nd 2025A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.
Read More
Linking Data to Determine Risk for 30-Day Readmissions in Dementia
December 22nd 2025This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.
Read More
Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures
December 19th 2025Limiting health-related social needs screening to lower-income areas would reduce screening burdens; however, this study found a 2-stage screening approach based on geography to be suboptimal.
Read More
Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes
December 17th 2025Medicaid’s Institution for Mental Diseases (IMD) rule bars federal funding for psychiatric facilities with more than 16 beds, but findings indicate that state waivers allowing treatment of serious mental illness in IMDs do not increase overall psychiatric hospitalizations.
Read More